The use of epitope arrays in immunodiagnosis of infectious disease: hepatitis C virus, a case study.

Serodiagnosis of infectious disease is often based on the detection of pathogen-specific antibodies in a patient's blood. For this, mixtures of pathogen-related antigens are used as bait to capture corresponding antibodies in solid phase immunoassays such as enzyme immunoassay (EIA). Western blots provide improved diagnostic power as compared with EIA due to the fact that the mixture of markers in the EIA well is resolved and tested as individual antigens on the Western blot. Hence, confirmation of EIA results is accomplished using the antigen arrays of Western blots. Here we took this approach one step further and tested the attributes of using epitope arrays in a diagnostic platform coined "combinatorial diagnostics." As a case in point, we tested a panel of phage-displayed epitope-based markers in the serodiagnosis of hepatitis C virus (HCV). The repertoire of HCV antigens was deconvoluted into panels of distinct linear and conformational epitopes and tested individually by quantitative EIA. Combinatorial diagnostics proved to be effective for the discrimination between positive and negative sera as well as serotyping of HCV.

[1]  M. Mondelli,et al.  Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody , 1994, Journal of virology.

[2]  D. MacPhee Methodological considerations for improving Western blot analysis. , 2010, Journal of pharmacological and toxicological methods.

[3]  P. Hornbeck,et al.  Enzyme‐Linked Immunosorbent Assays , 1992, Current protocols in immunology.

[4]  K. Chayama,et al.  Factors predictive of response to interferon‐α therapy in hepatitis C virus infection , 1994, Hepatology.

[5]  K. Vattem,et al.  Performing and optimizing Western blots with an emphasis on chemiluminescent detection. , 2009, Methods in enzymology.

[6]  V. Petrenko,et al.  Design of specific immunogens using filamentous phage as the carrier. , 1993, Gene.

[7]  G. Morris,et al.  Hepatitis C epitopes from phage‐displayed cDNA libraries and improved diagnosis with a chimeric antigen , 2000, Journal of medical virology.

[8]  Franco Felici,et al.  Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients , 2003, International journal of cancer.

[9]  K. Reddy,et al.  Hepatitis C Virus Genotypes in the United States: Epidemiology, Pathogenicity, and Response to Interferon Therapy , 1996, Annals of Internal Medicine.

[10]  E. Kolho Specificity and sensitivity of first and second generation anti‐HCV ELISA in a low prevalence population , 1992, Transfusion medicine.

[11]  S. Richter Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection , 2002, Journal of Clinical Microbiology.

[12]  J. Gershoni,et al.  Phage Display Selection, Analysis, and Prediction of B Cell Epitopes , 2009, Current protocols in immunology.

[13]  A. Meola,et al.  Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. , 1996, Journal of immunology.

[14]  N. Haigwood,et al.  Differentiation of a passive vaccine and the humoral immune response toward infection: analysis of phage displayed peptides. , 2006, Vaccine.

[15]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[16]  Y. Wang,et al.  Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C , 1994, Journal of medical virology.

[17]  M. Pirisi,et al.  Identification of four epitopes in hepatitis C virus core protein , 1993, Journal of clinical microbiology.

[18]  Y. Shemer-Avni,et al.  Hepatitis C virus infection and genotypes in Southern Israel and the Gaza strip , 1998, Journal of medical virology.

[19]  Stephen L. Chen,et al.  The Natural History of Hepatitis C Virus (HCV) Infection , 2006, International journal of medical sciences.

[20]  Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase , 2004, Journal of medical virology.

[21]  J. Gershoni,et al.  The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd. , 2001, Nucleic acids research.

[22]  G. Paranhos-Baccala,et al.  HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: Characterization of major epitopes useful for antigen detection , 1998, Journal of medical virology.

[23]  B. Kurien,et al.  An overview of Western blotting for determining antibody specificities for immunohistochemistry. , 2011, Methods in molecular biology.

[24]  G. Opdenakker,et al.  Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus , 1995, Journal of medical virology.

[25]  J. Schapiro,et al.  Hepatitis C at the Israeli National Hemophilia Center , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[26]  B. Wahrén,et al.  Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site. , 1992, Immunology letters.

[27]  G. E. Morris,et al.  Identification of antigenic sites on three hepatitis C virus proteins using phage‐displayed peptide libraries , 1998, Journal of medical virology.

[28]  H J Alter,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.

[29]  J. Glenn,et al.  The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy , 2009, PloS one.

[30]  E. Stura,et al.  Crystal Structure of a Hydrophobic Immunodominant Antigenic Site on Hepatitis C Virus Core Protein Complexed to Monoclonal Antibody 19D9D6 1 , 2003, The Journal of Immunology.

[31]  F. Fabrizi,et al.  Automated RIBA Hepatitis C Virus (HCV) Strip Immunoblot Assay for Reproducible HCV Diagnosis , 1998, Journal of Clinical Microbiology.

[32]  K. Matsumoto,et al.  Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens , 1993, Journal of clinical microbiology.

[33]  G. Davis,et al.  Factors predictive of a beneficial response to therapy of hepatitis C , 1997, Hepatology.

[34]  J. Gershoni,et al.  Site directed biotinylation of filamentous phage structural proteins , 2011, Virology Journal.

[35]  Darius Moradpour,et al.  Replication of hepatitis C virus , 2007, Nature Reviews Microbiology.

[36]  W. Maskill,et al.  4 Application of Protein Blotting to the Serodiagnosis of Human Immunodeficiency Virus Infection , 1989 .

[37]  S. Lambert,et al.  Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. , 1995, Virology.

[38]  M. Houghton The long and winding road leading to the identification of the hepatitis C virus. , 2009, Journal of hepatology.

[39]  A. Palacios,et al.  Development of low cost peptide‐based anti‐hepatitis C virus screening and confirmatory assays: Comparison with commercially available tests , 1999, Journal of medical virology.

[40]  B. Wahrén,et al.  Immunodominant regions within the hepatitis C virus core and putative matrix proteins , 1992, Journal of clinical microbiology.

[41]  L. Peruski,et al.  Immunological Methods for Detection and Identification of Infectious Disease and Biological Warfare Agents , 2003, Clinical Diagnostic Laboratory Immunology.

[42]  Darius Moradpour,et al.  Structural biology of hepatitis C virus , 2004, Hepatology.

[43]  H. Grisé,et al.  Cellular and molecular biology of HCV infection and hepatitis. , 2009, Clinical science.

[44]  T. Berg,et al.  Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes. , 1996, Journal of hepatology.

[45]  F. Felici,et al.  ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum. , 2001, European journal of biochemistry.

[46]  P. Simmonds,et al.  Sequence variability of hepatitis C virus and its clinical relevance , 1994, Journal of viral hepatitis.